Listen Now: 
Maori tobacco control advocate Marewa Glover says confirmation by New Zealand researchers of the effectiveness of a low cost smoking cessation product from Eastern Europe offers new hope for Maori.
The prestigious New England Medical Journal has published the results of a trial by Auckland University’s National Institute for Health Innovation into Cytisine, which was given to a large sample of people who called Quitline.
After six months they were twice as likely to have quit smoking at six months than smokers given nicotine replacement therapy.
Dr Glover, who was one of the authors, says the natural, plant-based compound has been commercially produced in Bulgaria and Poland for 40 years, but there were no English-language studies of it.
She and two colleagues did an earlier study on Cytisine because of its presence in some New Zealand native trees.
Copyright © 2014, UMA Broadcasting Ltd: www.waateanews.com
RELATED NEWS
